Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Organic Chemistry >  Heterocyclic Compounds >  Methyl 3-broMo-6-chloropyrazine-2-carboxylate

Methyl 3-broMo-6-chloropyrazine-2-carboxylate

Basic information Safety Supplier Related

Methyl 3-broMo-6-chloropyrazine-2-carboxylate Basic information

Product Name:
Methyl 3-broMo-6-chloropyrazine-2-carboxylate
Synonyms:
  • Methyl 3-broMo-6-chloropyrazine-2-carboxylate
  • 3-Bromo-6-chloro-pyrazine-2-carboxylic acid methyl ester
  • 2-Pyrazinecarboxylic acid, 3-bromo-6-chloro-, methyl ester
CAS:
13457-28-8
MF:
C6H4BrClN2O2
MW:
251.47
Mol File:
13457-28-8.mol
More
Less

Methyl 3-broMo-6-chloropyrazine-2-carboxylate Chemical Properties

Melting point:
35-36 °C
Boiling point:
292.4±35.0 °C(Predicted)
Density 
1.772±0.06 g/cm3(Predicted)
storage temp. 
under inert gas (nitrogen or Argon) at 2-8°C
pka
-3.78±0.10(Predicted)
Appearance
White to light yellow <35°C Solid,>36°C Liquid
More
Less

Methyl 3-broMo-6-chloropyrazine-2-carboxylate Usage And Synthesis

Uses

Methyl 3-broMo-6-chloropyrazine-2-carboxylate is an important intermediate for the synthesis of a class of antitumour drugs, SHP2 inhibitors, which can be used in the pharmaceutical development process.

Synthesis

1458-03-3

13457-28-8

The general procedure for the synthesis of methyl 3-bromo-6-chloropyrazine-2-carboxylate from methyl 3-amino-6-chloropyrazine-2-carboxylate was as follows: 100 mL of acetic acid was added to a 500 mL three-necked flask and cooled to 0 °C. Methyl 3-amino-6-chloropyrazine-2-carboxylate (20 g, 0.11 mol) was slowly added dropwise to 100 mL of aqueous hydrogen bromide solution at 0 °C. The dropwise addition process was continued for 30 min to ensure complete reaction. Subsequently, 50 mL of aqueous sodium nitrite (20.7 g, 0.33 mol) was slowly added dropwise while maintaining 0°C. After 30 minutes of reaction, the completion of the reaction was confirmed and 30 mL of 10% sodium bisulfite solution was added to terminate the reaction. The reaction mixture was extracted with ethyl acetate (200 mL x 2 times), the organic phases were combined and dried with 20 g of anhydrous sodium sulfate. After filtration, the filtrate was concentrated under reduced pressure to give methyl 3-bromo-6-chloropyrazine-2-carboxylate (23.3 g, 87% yield) as a white solid.

References

[1] Patent: CN108101857, 2018, A. Location in patent: Paragraph 0035-0037

Methyl 3-broMo-6-chloropyrazine-2-carboxylateSupplier

PharmaBlock Sciences (Nanjing),Inc.
Tel
025-86918202 4000255188
Email
sales@pharmablock.com
shanghai Rainbow MediTech.Co.Ltd.
Tel
021-64968085,64968086-5815,5812; 13472757003
Email
xiaoxia.zeng@rainbowpharma.cn
Kohn & Shawn Pharmatech Co.,Ltd
Tel
0931-4190454 13893344397
Email
sales@kyxpharma.com
Shanghai Jian Chao Chemical Technology Co., Ltd.
Tel
150-2103-5486 18017383231
Email
983544897@qq.com
SynAsst Chemical.
Tel
021-60343070